Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Extension Study to Assess Safety and Efficacy of Mylan's Insulin Glargine and Lantus® in Type 1 Diabetes Mellitus (T1DM) Patients

ClinicalTrials.gov ID: NCT02666430

Public ClinicalTrials.gov record NCT02666430. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:10 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label, Randomized, Multi-center, Parallel-Group Clinical Trial Comparing the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 1 Diabetes Mellitus Patients: An Extension Study

Study identification

NCT ID
NCT02666430
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Mylan Inc.
Industry
Enrollment
127 participants

Conditions and interventions

Interventions

  • Mylan's insulin glargine Drug
  • Lantus® Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 66 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2015
Primary completion
Feb 28, 2017
Completion
Jun 30, 2017
Last update posted
Mar 2, 2022

2015 – 2017

United States locations

U.S. sites
39
U.S. states
18
U.S. cities
39
Facility City State ZIP Site status
Mylan Investigator Site Fresno California 93720
Mylan Investigator Site Greenbrae California 94904
Mylan Investigator Site La Jolla California 92037
Mylan Investigator Site Northridge California 91324
Mylan Investigator Site Tustin California 92780
Mylan Investigator Site Fort Lauderdale Florida 33312
Mylan Investigator Site New Port Richey Florida 34652
Mylan Investigator Site Palm Harbor Florida 34684
Mylan Investigator Site West Palm Beach Florida 33401
Mylan Investigator Site Atlanta Georgia 30318
Mylan Investigator Site Columbus Georgia 31904
Mylan Investigator Site Idaho Falls Idaho 83404
Mylan Investigator Site Crystal Lake Illinois 60012
Mylan Investigator Site Springfield Illinois 62711
Mylan Investigator Site Des Moines Iowa 50314
Mylan Investigator Site Overland Park Kansas 66210
Mylan Investigator Site Lexington Kentucky 40503
Mylan Investigator Site Billings Montana 59101
Mylan Investigator Site Omaha Nebraska 68131
Mylan Investigator Site Albany New York 12206
Mylan Investigator Site Staten Island New York 10301
Mylan Investigator Site Syracuse New York 13210
Mylan Investigator Site Asheville North Carolina 28803
Mylan Investigator Site Burlington North Carolina 27215
Mylan Investigator Site Greenville North Carolina 27834
Mylan Investigator Site Morehead City North Carolina 28557
Mylan Investigator Site Wilmington North Carolina 28401
Mylan Investigator Site Cincinnati Ohio 45236
Mylan Investigator Site Mentor Ohio 44060
Mylan Investigator Site Chattanooga Tennessee 37411
Mylan Investigator Site Austin Texas 78731
Mylan Investigator Site Dallas Texas 75231
Mylan Investigator Site San Antonio Texas 78258
Mylan Investigator Site Ogden Utah 84405
Mylan Investigator Site Salt Lake City Utah 84121
Mylan Investigator Site Chesapeake Virginia 23321
Mylan Investigator Site Renton Washington 98057
Mylan Investigator Site Tacoma Washington 98405
Mylan Investigator Site Vancouver Washington 98664

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 42 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02666430, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 2, 2022 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02666430 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →